Source: Biochemical Pharmacology. Unidade: ESALQ
Subjects: ÁCIDOS GRAXOS, BIOTA INTESTINAL, DOENÇAS PARASITÁRIAS, EPIGÊNESE GENÉTICA, HELMINTÍASE, PROBIÓTICOS
ABNT
SCHEMCZSSEN-GRAEFF, Zelinda et al. Probiotics as a strategy for addressing helminth infections in low-income countries: Working smarter rather than richer. Biochemical Pharmacology, v. 226, p. 1-16, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2024.116363. Acesso em: 31 out. 2024.APA
Schemczssen-Graeff, Z., Silva, C. R., Freitas, P. N. N. de, Constantin, P. P., Pileggi, S. A. V., Olchanheski, L. R., & Pileggi, M. (2024). Probiotics as a strategy for addressing helminth infections in low-income countries: Working smarter rather than richer. Biochemical Pharmacology, 226, 1-16. doi:10.1016/j.bcp.2024.116363NLM
Schemczssen-Graeff Z, Silva CR, Freitas PNN de, Constantin PP, Pileggi SAV, Olchanheski LR, Pileggi M. Probiotics as a strategy for addressing helminth infections in low-income countries: Working smarter rather than richer [Internet]. Biochemical Pharmacology. 2024 ; 226 1-16.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bcp.2024.116363Vancouver
Schemczssen-Graeff Z, Silva CR, Freitas PNN de, Constantin PP, Pileggi SAV, Olchanheski LR, Pileggi M. Probiotics as a strategy for addressing helminth infections in low-income countries: Working smarter rather than richer [Internet]. Biochemical Pharmacology. 2024 ; 226 1-16.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bcp.2024.116363